Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 07 Oct 2026 for PTC Therapeutics, INC., €572k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Section Six Partners, L.P.: trading record in brief
Section Six Partners, L.P. discloses dealings in PTC Therapeutics, Inc. to SEC (Form 4). Between 19 August 2026 and 7 October 2026, the trades on record add up to 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 7 October 2026: a transaction of €572k, in PTC Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Section Six Partners, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
10,000 shares@ US$64.35CommonSEC144:0001628280-26-065336
40,000 shares@ US$68.500.051% mcap42.8% of flowCommonSEC144:0001628280-26-061154
50,000 shares@ US$73.000.069% mcap57.2% of flowCommonSEC144:0001628280-26-058901
3 of 3 declarations
